Chemkart India Limited reported its audited standalone and consolidated financial results for the financial year ended March 31, 2026. The company posted consolidated revenue from operations of ₹21,482.91 lakh for FY26, an increase of 5.7% compared to ₹20,327.85 lakh in the previous year. Profit after tax on a consolidated basis stood at ₹1,965.5 lakh, a decrease of 19.9% from ₹2,453.3 lakh in FY25. The statutory auditors, M/s Bagaria & Co. LLP, issued an unmodified opinion on the financial results.

Financial Performance

The company delivered a measured performance amid a challenging global operating environment, impacted by supply chain disruptions and pricing corrections. Despite these headwinds, revenue was supported by healthy volume growth of approximately 7.1%. The following table summarises the key financial metrics for FY26 on both a standalone and consolidated basis:

For the half-year ended March 31, 2026, standalone revenue from operations was ₹11,050.78 lakh with a profit after tax of ₹1,010.20 lakh. On a consolidated basis, the half-year revenue was ₹11,160.36 lakh with a profit after tax of ₹950.57 lakh. The consolidated net worth strengthened significantly to ₹12,972.98 lakh as of March 31, 2026, from ₹5,328.22 lakh in the prior year, supported by IPO proceeds and sustained earnings growth.

Balance Sheet and Working Capital

The consolidated total assets stood at ₹15,671.1 lakh as of March 31, 2026, up from ₹8,643.9 lakh in the previous year. The table below presents the key asset and working capital metrics:

Cash and cash equivalents increased significantly to ₹3,864.5 lakh from ₹283.1 lakh, bolstered by IPO proceeds. Current borrowings reduced to ₹495.3 lakh from ₹1,692.6 lakh, reinforcing the company's low-leverage position. Capital Work-in-Progress rose to ₹486.8 lakh, reflecting continued progress in the development of the Easy Raw Materials Private Limited (ERMPL) manufacturing facility at JNPA SEZ, Navi Mumbai.

Strategic Outlook

As on March 31, 2026, the company maintained strong business visibility with advance and open orders exceeding ₹6,526 lakh. The company remains focused on research and development, product innovation, and advanced nutraceutical technologies. The ERMPL manufacturing facility at JNPA SEZ is progressing with civil foundation and plinth-level execution activities underway, marking a key milestone in enhancing manufacturing capabilities and improving export competitiveness.

Chemkart India Limited has filed an intimation with BSE Limited, notifying of an upcoming Board of Directors meeting scheduled for Monday, May 18, 2026. The filing was made on May 7, 2026, by Chief Financial Officer Basavaraj Shankar Dalawai, pursuant to Regulation 29(1), Regulation 33, and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to consider and approve key financial matters. The following items are on the agenda:

• Audited Standalone and Consolidated Financial Results for the half year and the financial year ended March 31, 2026
• Any other matter with the permission of the Chair

The table below summarizes the key details of the scheduled board meeting:

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in equity shares of the company by designated persons and their immediate relatives has been closed. The closure was communicated to BSE Limited vide letter dated March 19, 2026, and will remain in effect until 48 hours after the declaration of the audited standalone and consolidated financial results for the half year and the financial year ended March 31, 2026.